These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 27025360)

  • 1. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
    Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
    Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
    Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
    Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.
    Batman B; van Bladel ER; van Hamersveld M; Pasker-de Jong PCM; Korporaal SJA; Urbanus RT; Roest M; Boven LA; Fijnheer R
    Vox Sang; 2017 Nov; 112(8):773-779. PubMed ID: 28960383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.
    Mo A; Wood E; Shortt J; Hu E; McQuilten Z
    Eur J Haematol; 2023 Oct; 111(4):592-600. PubMed ID: 37452616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
    Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
    Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
    Opheim EN; Apelseth TO; Stanworth SJ; Eide GE; Hervig T
    Vox Sang; 2017 Aug; 112(6):578-585. PubMed ID: 28639693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
    Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
    Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function tests predict bleeding in patients with acute myeloid leukemia and thrombocytopenia.
    Just Vinholt P; Højrup Knudsen G; Sperling S; Frederiksen H; Nielsen C
    Am J Hematol; 2019 Aug; 94(8):891-901. PubMed ID: 31119762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.
    Warner MA; Chandran A; Frank RD; Kor DJ
    Anesth Analg; 2019 Feb; 128(2):288-295. PubMed ID: 29293185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of lower neonatal platelet transfusion thresholds.
    Hasan R; Saifee NH
    Transfusion; 2021 Jun; 61(6):1672-1675. PubMed ID: 33786866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.